This is a single-center, non-interventional, retrospective study of data, at the level of the individual without identification, extracted from medical records of adult patients undergoing a kidney transplant procedure after 1st from January 2018 until reaching the sample size enrollment (around 500 individuals); this refers to the period of verification of individuals' eligibility for entry into the study. Individuals under strategy preemptive patients who developed CMV infection/disease within 12 months after transplantation. The data will be collected from date of transplant (including pre-transplant clinical history) until completion of at least 12 months after transplantation, or until graft loss, or recipient death or loss to follow-up, when/if applicable.
Data will be collected from medical records and will include transplant recipient characteristics, transplant-related information, CMV status, clinical outcomes, treatment patterns, healthcare resource utilization and captured on an electronic Intake Form. Study-specific Case Report (eCRF) The sponsor will create a Statistical Analysis Plan (SAP) before collection begins of data. The eCRF system will comply with research regulations
Study Type
OBSERVATIONAL
Enrollment
500
Hospital do Rim
São Paulo, Brazil
Incidence of infection, CMV disease, and tissue invasive disease.
Incidence of infection, CMV disease, and tissue invasive disease.
Time frame: 12 months
Incidence recurrent CMV infection/disease
Incidence recurrent CMV infection/disease
Time frame: 12 months
Incidence of refractory CMV infection/disease
Incidence of refractory CMV infection/disease
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.